Back to CGEM

MPM BioImpact LLC → CGEM

MPM BioImpact LLC CGEM Position History

Cullinan Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$149.2M
Q3 2026
Peak value
$177.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$79.2M
Q1 2026$108.7M
Q2 2026$177.2M
Q3 2026$149.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$149.2M9.72M——
Q2 2026$177.2M9.73M——
Q1 2026$108.7M7.65M——
Q4 2025$79.2M7.65M——

Other funds holding CGEM

Other MPM BioImpact LLC positions

AKTS

Aktis Oncology, Inc.

$155.9M
LQDA

Liquidia Corporation

$110.5M
DBVTF

DBV Technologies S A

$108.9M
AKTS

Aktis Oncology, Inc.

$94.2M
RVMDW

Revolution Medicines, Inc.

$92.2M
AKTS

Aktis Oncology, Inc.

$86.5M
CORT

Corcept Therapeutics, Inc.

$67M
EWTX

Edgewise Therapeutics Inc

$65.9M